Frapaise Francois-Xavier 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Nov 16, 2010
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Other
Common stock
2010-11-15$7.71/sh+1,305$10,061→ 4,211 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on November 15, 2010.